{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:02:48Z","timestamp":1769688168556,"version":"3.49.0"},"posted":{"date-parts":[[2026,1,29]]},"group-title":"In Review","reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,12,4]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  PTEN hamartoma tumor syndrome (PHTS) is a cancer predisposition disorder caused by germline\n                  <italic>PTEN<\/italic>\n                  variants, yet its full clinical spectrum remains poorly defined due to reliance on highly selected cohorts. Accordingly, PHTS is underrecognized and its prevalence underestimated. Leveraging genomic and electronic health record data from 414,830 participants in the All of Us (AoU) Research Program, we identified 55 individuals with pathogenic or likely pathogenic\n                  <italic>PTEN<\/italic>\n                  variants, the majority of whom lacked a prior PHTS diagnosis, underscoring underrecognition in the general population. PHTS affects\u2009~\u20091\/7500 individuals in this US cohort, which is about 26-folds higher than historical estimates for\n                  <italic>PTEN<\/italic>\n                  -related disorder. Compared with carriers of other cancer-related gene variants and noncarriers,\n                  <italic>PTEN<\/italic>\n                  variant carriers exhibited the highest cancer prevalence and significantly younger ages at first cancer diagnosis. Phenotype enrichment revealed expected overgrowth-related features as well as previously unreported associations, including adenotonsillar hypertrophy, sleep apnea, acanthosis nigricans, and extreme obesity, suggesting broader systemic involvement than classically appreciated. Variant spectra were consistent across the population-based and clinically-ascertained PHTS cohorts. These findings demonstrate that PHTS is more prevalent, more heterogeneous, and more often undiagnosed than current clinical practice reflects, emphasizing the value of population-scale genomics for comprehensive characterization and earlier detection of PHTS.\n                <\/p>","DOI":"10.21203\/rs.3.rs-8279719\/v1","type":"posted-content","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:55:50Z","timestamp":1769648150000},"source":"Crossref","is-referenced-by-count":0,"title":["Population-based Characterization of PTEN Hamartoma Tumor Syndrome"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0338-5239","authenticated-orcid":false,"given":"Ying","family":"Ni","sequence":"first","affiliation":[{"name":"Cleveland Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Idumah","sequence":"additional","affiliation":[{"name":"Cleveland Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Bautista","sequence":"additional","affiliation":[{"name":"Cleveland Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-9182","authenticated-orcid":false,"given":"Lin","family":"Li","sequence":"additional","affiliation":[{"name":"Cleveland Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamis","family":"Yehia","sequence":"additional","affiliation":[{"name":"Cleveland Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","author":"Yehia L","year":"1993","unstructured":"Yehia L, Eng C. PTEN Hamartoma Tumor Syndrome. In: GeneReviews((R)) (eds Adam MP, et al.) (1993)."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-052218-125823","article-title":"The Clinical Spectrum of PTEN Mutations","volume":"71","author":"Yehia L","year":"2020","unstructured":"Yehia L, Keel E, Eng C. The Clinical Spectrum of PTEN Mutations. Annu Rev Med 71, 103\u2013116 (2020).","journal-title":"Annu Rev Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan MH","year":"2012","unstructured":"Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 18, 400\u2013407 (2012).","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jmedgenet-2012-101339","article-title":"High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome","volume":"50","author":"Bubien V,","year":"2013","unstructured":"Bubien V, et al. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet 50, 255\u2013263 (2013).","journal-title":"J Med Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10689-013-9674-3","article-title":"Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome","volume":"13","author":"Nieuwenhuis MH,","year":"2014","unstructured":"Nieuwenhuis MH, et al. Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome. Fam Cancer 13, 57\u201363 (2014).","journal-title":"Fam Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jnci\/djac188","article-title":"Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome","volume":"115","author":"Hendricks LAJ,","year":"2023","unstructured":"Hendricks LAJ, et al. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome. J Natl Cancer Inst 115, 93\u2013103 (2023).","journal-title":"J Natl Cancer Inst"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e239705","DOI":"10.1001\/jamanetworkopen.2023.9705","article-title":"Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants","volume":"6","author":"Yehia L,","year":"2023","unstructured":"Yehia L, et al. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants. JAMA Netw Open 6, e239705 (2023).","journal-title":"JAMA Netw Open"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1200\/JCO.2013.53.6656","article-title":"Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations","volume":"32","author":"Ngeow J","year":"2014","unstructured":"Ngeow J, Stanuch K, Mester JL, Barnholtz-Sloan JS, Eng C. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations. J Clin Oncol 32, 1818\u20131824 (2014).","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"101467","DOI":"10.1016\/j.gim.2025.101467","article-title":"The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)","author":"Hendricks LAJ,","year":"2025","unstructured":"Hendricks LAJ, et al. The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS). Genet Med, 101467 (2025).","journal-title":"Genet Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/jmg.2004.024646","article-title":"Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations","volume":"42","author":"Butler MG,","year":"2005","unstructured":"Butler MG, et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 42, 318\u2013321 (2005).","journal-title":"J Med Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cell.2019.12.036","article-title":"Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism","volume":"180","author":"Satterstrom FK,","year":"2020","unstructured":"Satterstrom FK, et al. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell 180, 568\u2013584 e523 (2020).","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1016\/j.cell.2022.10.009","article-title":"Genomic architecture of autism from comprehensive whole-genome sequence annotation","volume":"185","author":"Trost B,","year":"2022","unstructured":"Trost B, et al. Genomic architecture of autism from comprehensive whole-genome sequence annotation. Cell 185, 4409\u20134427.e4418 (2022).","journal-title":"Cell"},{"key":"ref13","article-title":"Population prevalence of the major thyroid cancer-associated syndromes","author":"White SL,","year":"2025","unstructured":"White SL, et al. Population prevalence of the major thyroid cancer-associated syndromes. J Clin Endocrinol Metab, (2025).","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.ejhg.5200289","article-title":"Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations","volume":"7","author":"Nelen MR,","year":"1999","unstructured":"Nelen MR, et al. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet 7, 267\u2013273 (1999).","journal-title":"Eur J Hum Genet"},{"key":"ref15","article-title":"Pathogenic Germline Variants in Cancer Susceptibility Genes","author":"Idumah G","year":"2025","unstructured":"Idumah G, Newell D, Hadrys M, Ribaudo I, Ni Y, Arbesman J. Pathogenic Germline Variants in Cancer Susceptibility Genes. JAMA, (2025).","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/ejhg.2011.20","article-title":"Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model","volume":"19","author":"Mester JL","year":"2011","unstructured":"Mester JL, Tilot AK, Rybicki LA, Frazier TW, 2nd, Eng C. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Eur J Hum Genet 19, 763\u2013768 (2011).","journal-title":"Eur J Hum Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"104364","DOI":"10.1016\/j.ejmg.2021.104364","article-title":"Red flags for early recognition of adult patients with PTEN Hamartoma Tumour Syndrome","volume":"64","author":"Drissen M","year":"2021","unstructured":"Drissen M, Schieving JH, Schuurs-Hoeijmakers JHM, Vos JR, Hoogerbrugge N. Red flags for early recognition of adult patients with PTEN Hamartoma Tumour Syndrome. Eur J Med Genet 64, 104364 (2021).","journal-title":"Eur J Med Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \"All of Us\" Research Program","volume":"381","author":"All of Us Research Program I,","year":"2019","unstructured":"All of Us Research Program I, et al. The \"All of Us\" Research Program. N Engl J Med 381, 668\u2013676 (2019).","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-022-04558-8","article-title":"A joint NCBI and EMBL-EBI transcript set for clinical genomics and research","volume":"604","author":"Morales J,","year":"2022","unstructured":"Morales J, et al. A joint NCBI and EMBL-EBI transcript set for clinical genomics and research. Nature 604, 310\u2013315 (2022).","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41698-025-00847-3","article-title":"Extended spectrum of cancers in PTEN hamartoma tumor syndrome","volume":"9","author":"Yehia L,","year":"2025","unstructured":"Yehia L, et al. Extended spectrum of cancers in PTEN hamartoma tumor syndrome. NPJ Precis Oncol 9, 61 (2025).","journal-title":"NPJ Precis Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/humu.23636","article-title":"Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel","volume":"39","author":"Mester JL","year":"2018","unstructured":"Mester JL, et al. Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel. Hum Mutat 39, 1581\u20131592 (2018).","journal-title":"Hum Mutat"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8279719\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8279719\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:55:53Z","timestamp":1769648153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8279719\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":21,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8279719\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,1,29]]},"subtype":"preprint"}}